Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Rigenerand, which is working on cGMP gene and cell therapies, developed a 3D bioreactor design for its own use. However, company officials soon began to sell it as a standalone product. The concept is to use it as an accelerator for validating the cell and gene therapy approach, specifically to validate CAR-T products against primary cells or cell lines during research and development.